XML 19 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statement of Cash Flows - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Cash flows from operating activities:          
Net income $ 60,883,000 $ 30,745,000 $ 92,580,000 $ 95,783,000  
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization     163,680,000 170,409,000  
Amortization of financing costs and discounts     21,393,000 9,072,000  
Non-cash operating lease costs     15,686,000 14,474,000  
Share-based compensation     18,643,000 18,394,000  
Provision for doubtful accounts     9,508,000 9,217,000  
Deferred income taxes, net     7,815,000 2,850,000  
Gain on sale of businesses (17,122,000) 0 (17,122,000) 0  
Lease asset impairments and other charges   0 9,786,000 0  
Changes in fair value of contingent consideration     (243,000) 8,044,000  
Foreign currency remeasurement gain     (15,919,000) 0  
Loss (income) on equity method investments     10,799,000 (166,000)  
Loss on equity and debt investments     20,826,000 0  
Decrease (increase) in:          
Accounts receivable     57,560,000 29,953,000  
Prepaid expenses and other current assets     (3,279,000) (10,094,000)  
Other assets     543,000 (1,528,000)  
Increase (decrease) in:          
Accounts payable and accrued expenses     (26,430,000) 623,000  
Income taxes payable     (496,000) (15,179,000)  
Deferred revenue     (10,494,000) 777,000  
Operating lease liabilities     (12,857,000) (13,612,000)  
Liability for uncertain tax positions     7,746,000 (9,144,000)  
Other long-term liabilities     6,284,000 (566,000)  
Net cash provided by operating activities     356,009,000 309,307,000  
Cash flows from investing activities:          
Distribution from equity method investment     0 10,288,000  
Purchases of equity method investment     (29,979,000) (22,338,000)  
Purchases of equity investments     (843,000) 0  
Purchases of property and equipment     (71,266,000) (49,483,000)  
Acquisition of businesses, net of cash received     (27,156,000) (411,349,000)  
Proceeds from sale of businesses     24,353,000 0  
Proceeds from sale of assets     507,000 0  
Purchases of intangible assets     (2,902,000) (46,000)  
Net cash used in investing activities     (107,286,000) (472,928,000)  
Cash flows from financing activities:          
Payment of note payable     (400,000) (5,100,000) $ (5,100,000)
Proceeds from line of credit     0 185,000,000  
Repayment of line of credit     0 (57,000,000)  
Repurchase of common stock     (238,905,000) (20,562,000)  
Issuance of common stock under employee stock purchase plan     3,303,000 1,995,000  
Exercise of stock options     952,000 5,274,000  
Dividends paid     0 (43,966,000)  
Deferred payments for acquisitions     (20,427,000) (17,734,000)  
Other     (1,377,000) (1,055,000)  
Net cash (used in) provided by financing activities     (256,854,000) 46,852,000  
Effect of exchange rate changes on cash and cash equivalents     446,000 (520,000)  
Net change in cash and cash equivalents     (7,685,000) (117,289,000)  
Cash and cash equivalents at beginning of period     575,615,000 209,474,000 209,474,000
Cash and cash equivalents at end of period $ 567,930,000 $ 92,185,000 $ 567,930,000 $ 92,185,000 $ 575,615,000